证券记录 · 已归档季度
COO
The Cooper Companies, Inc. · Healthcare · Medical - Instruments & Supplies
21被追踪持有人
0Δ持有人
75.38M持有股份
$5.36B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +1.8% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 149 | +2 | 133.62M | $9.60B | +8 | −7 |
| Q1 2026 | 151 | +1 | 132.75M | $9.51B | +6 | −6 |
| Q4 2025 | 149 | -1 | 147.94M | $12.12B | +1 | −1 |
| Q3 2025 | 22 | -1 | 84.49M | $5.79B | n/a | −2 |
| Q2 2025 | 21 | 0 | 75.38M | $5.36B | +1 | −1 |
| Q1 2025 | 18 | -4 | 34.09M | $2.87B | n/a | −4 |
| Q4 2024 | 22 | +2 | 30.60M | $2.81B | +2 | n/a |
| Q3 2024 | 19 | +3 | 19.38M | $2.14B | +3 | n/a |
| Q2 2024 | 16 | n/a | 16.68M | $1.46B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 24.25M | n/a | $1.73B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 15.45M | n/a | $1.10B | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 3 | State Street Global Advisors ✦ (被动) | 8.66M | +1.2% | $616.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Capital World Investors ✦ | 8.39M | +8.3% | $597.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 6.55M | +65.5% | $465.91M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (被动) | 5.21M | +2.5% | $368.89M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 1.95M | -24.3% | $138.85M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.43M | +753.3% | $101.67M | 0.0% | ▲ Add | 5 | SEC ↗ ×6 |
| 9 | Point72 Asset Management ✦ | 615.96K | -19.9% | $43.83M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 546.89K | -32.1% | $38.92M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 521.71K | +2.2% | $37.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 492.71K | -79.3% | $35.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 397.32K | +65.4% | $28.27M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Glenview Capital ✦ | 280.69K | 新增 | $19.97M | 0.6% | New | 1 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 217.94K | n/a | $15.51M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 16 | Adage Capital Partners ✦ | 183.16K | +0.6% | $13.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 91.08K | -26.7% | $6.48M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 18 | Fisher Asset Management ✦ | 77.99K | -31.2% | $5.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 44.00K | 0.0% | $3.13M | 0.0% | Held | 5 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 11.90K | +133.9% | $846,519 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 6.52K | -23.3% | $463,679 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Glenview Capital | $19.97M | 0.6% |
已清仓
| Marshall Wace | $69.67M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 664 持有人, 203.43M 股份, $13.35B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Sep 16
Kurzius Lawrence Erik
Director · 10.00K 股 @ 54.93 · $549,320
Sep 14
Kurzius Lawrence Erik
Director · 10.00K 股 @ 53.91 · $539,150
Sep 14
Rosebrough Walter M Jr
Director · 3.00K 股 @ 54.29 · $162,870
Sep 11
Rosebrough Walter M Jr
Director · 7.00K 股 @ 54.11 · $378,770
Sep 11
Keel Paul A
Director · 4.70K 股 @ 53.18 · $250,000
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据